ranolazine has been researched along with quercetin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Babu, KN; Babu, PJ; Babu, PR; Peter, PL; Rajesh, K | 1 |
| Cerri, C; Colucci, P; Corsi, F; Ferraro, E; Gabellini, C; Lai, M; Leigheb, M; Maya-Vetencourt, JF; Piano, I; Puppi, D; Vitolo, S; Votta, A | 1 |
4 other study(ies) available for ranolazine and quercetin
| Article | Year |
|---|---|
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Influence of quercetin on the pharmacokinetics of ranolazine in rats and in vitro models.
Topics: Acetanilides; Animals; Antioxidants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chickens; Drug Interactions; Enzyme Inhibitors; Intestinal Absorption; Male; Organ Culture Techniques; Piperazines; Quercetin; Ranolazine; Rats; Rats, Wistar; Sodium Channel Blockers | 2013 |
Anti-inflammatory reprogramming of microglia cells by metabolic modulators to counteract neurodegeneration; a new role for Ranolazine.
Topics: Anti-Inflammatory Agents; Humans; Inflammation; Lipopolysaccharides; Microglia; Neurodegenerative Diseases; Neuroprotective Agents; Quercetin; Ranolazine | 2023 |